Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in pigs
The ineffectiveness of simple delivery of soluble antigens to mucosal membranes for immunization has stimulated extensive studies of strategies for appropriate delivery systems and adjuvants. Biphasic lipid vesicles are formulations suitable for the delivery of proteins, peptides, and oligo/polynucleotides. The purpose of these studies was to investigate the ability of biphasic lipid vesicles (as vaccinetargeting adjuvants) containing a bacterial antigen and unmethylated oligonucleotides containing CGdinucleotides-CpG motifs (CpG ODNs) to induce systemic and mucosal immune responses in pigs. Results showed that while the protein, either alone or with CpG ODNs, did not induce mucosal immune responses, administration of antigen and CpG ODNs in biphasic lipid vesicles resulted in induction of boty systemic and local antibody responses after immunization using a combined mucosal/systemic approach.
KeywordsMucosal immunity biphasic lipid delivery systems CpG ODNs porcine Actinobacillus pleuropneumoniae
- 1.Goonetilleke NP, McShane H, Hannan CM, Anderson RJ, Brookes RH, Hill AV. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modofied vaccinia virus Ankara.J Immunol. 2003;171:1602–1609.PubMedGoogle Scholar
- 16.Foldvari M, inventor. US patent 5 853 755. December 29, 1998.Google Scholar
- 17.Foldvari M, Baca-Estrada ME, inventor. US patent 5 993 852. November 30, 1999.Google Scholar